The 6 analysts offering 12-month price forecasts for Affimed NV have a median target of 5.04, with a high estimate of 12.91 and a low estimate of 0.99. The median estimate represents a +1,145.09% increase from the last price of 0.41.
The current consensus among 8 polled investment analysts is to Buy stock in Affimed NV. This rating has held steady since December, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.18
Reporting Date Mar 20
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.